LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation

    Markus W. Löffler / Julia Steinhilber / Franz J. Hilke / Sebastian P. Haen / Hans Bösmüller / Ivonne-Aidee Montes-Mojarro / Irina Bonzheim / Antje Stäbler / Ulrike Faust / Ute Grasshoff / Ingmar Königsrainer / Hans-Georg Rammensee / Lothar Kanz / Alfred Königsrainer / Stefan Beckert / Olaf Riess / Christopher Schroeder

    BMC Medical Genetics, Vol 19, Iss 1, Pp 1-

    a combination of extremely rare diseases with probable further implications

    2018  Volume 7

    Abstract: Abstract Background The PTEN-hamartoma-tumor-syndrome (PHTS) is caused by germline mutations in Phosphatase and Tensin homolog (PTEN) and predisposes to the development of several typical malignancies. Whereas PTEN mutations have been implicated in the ... ...

    Abstract Abstract Background The PTEN-hamartoma-tumor-syndrome (PHTS) is caused by germline mutations in Phosphatase and Tensin homolog (PTEN) and predisposes to the development of several typical malignancies. Whereas PTEN mutations have been implicated in the occurrence of malignant mesotheliomas, the genetic landscape of verrucous carcinomas (VC) is largely uncharted. Both VC and malignant peritoneal mesotheliomas (MPM) are exceedingly rare and a potential link between these malignancies and PHTS has never been reported. Case presentation We here describe the clinical course of a PHTS patient who, in addition to a typical thyroid carcinoma at the age of 36 years, developed a highly-differentiated oral VC and an epithelioid MPM six years later. The patient with a history of occupational asbestos exposure underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for MPM. The clinical diagnosis of PHTS was consequently corroborated by a germline PTEN deletion. Sequencing of tumor tissue revealed a second hit in PTEN in the thyroid carcinoma and VC, confirmed by a PTEN loss and activation of the PI3K/AKT pathway in immunohistochemistry. Furthermore, additional somatic mutations in the thyroid carcinoma as well as in the VC were detected, whereas the genetics of MPM remained unrevealing. Discussion and conclusions We here report the very unusual clinical course of a patient with rare tumors that have a germline mutation first hit in PTEN in common. Since this patient was exposed to asbestos and current evidence suggests molecular mechanisms that might render PHTS patients particularly susceptible to mesothelioma, we strongly recommend PHTS patients to avoid even minimal exposure.
    Keywords Malignant Peritoneal Mesothelioma ; PTEN-Hamartoma-Tumor-Syndrome ; Hereditary Tumor Syndrome ; Verrucous Carcinoma ; Case Report ; Internal medicine ; RC31-1245 ; Genetics ; QH426-470
    Subject code 610 ; 616
    Language English
    Publishing date 2018-08-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

    Markus W. Löffler / Christopher Mohr / Leon Bichmann / Lena Katharina Freudenmann / Mathias Walzer / Christopher M. Schroeder / Nico Trautwein / Franz J. Hilke / Raphael S. Zinser / Lena Mühlenbruch / Daniel J. Kowalewski / Heiko Schuster / Marc Sturm / Jakob Matthes / Olaf Riess / Stefan Czemmel / Sven Nahnsen / Ingmar Königsrainer / Karolin Thiel /
    Silvio Nadalin / Stefan Beckert / Hans Bösmüller / Falko Fend / Ana Velic / Boris Maček / Sebastian P. Haen / Luigi Buonaguro / Oliver Kohlbacher / Stefan Stevanović / Alfred Königsrainer / HEPAVAC Consortium / Hans-Georg Rammensee

    Genome Medicine, Vol 11, Iss 1, Pp 1-

    2019  Volume 16

    Abstract: Abstract Background Although mutated HLA ligands are considered ideal cancer-specific immunotherapy targets, evidence for their presentation is lacking in hepatocellular carcinomas (HCCs). Employing a unique multi-omics approach comprising a neoepitope ... ...

    Abstract Abstract Background Although mutated HLA ligands are considered ideal cancer-specific immunotherapy targets, evidence for their presentation is lacking in hepatocellular carcinomas (HCCs). Employing a unique multi-omics approach comprising a neoepitope identification pipeline, we assessed exome-derived mutations naturally presented as HLA class I ligands in HCCs. Methods In-depth multi-omics analyses included whole exome and transcriptome sequencing to define individual patient-specific search spaces of neoepitope candidates. Evidence for the natural presentation of mutated HLA ligands was investigated through an in silico pipeline integrating proteome and HLA ligandome profiling data. Results The approach was successfully validated in a state-of-the-art dataset from malignant melanoma, and despite multi-omics evidence for somatic mutations, mutated naturally presented HLA ligands remained elusive in HCCs. An analysis of extensive cancer datasets confirmed fundamental differences of tumor mutational burden in HCC and malignant melanoma, challenging the notion that exome-derived mutations contribute relevantly to the expectable neoepitope pool in malignancies with only few mutations. Conclusions This study suggests that exome-derived mutated HLA ligands appear to be rarely presented in HCCs, inter alia resulting from a low mutational burden as compared to other malignancies such as malignant melanoma. Our results therefore demand widening the target scope for personalized immunotherapy beyond this limited range of mutated neoepitopes, particularly for malignancies with similar or lower mutational burden.
    Keywords Hepatocellular carcinoma ; HLA ; HLA ligandomics ; Immunoinformatics ; Immunotherapy ; Liver cancer ; Medicine ; R ; Genetics ; QH426-470
    Subject code 616
    Language English
    Publishing date 2019-04-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top